[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

U.S. Orthopedic Biomaterials Market

December 2014 | 288 pages | ID: UFFA242CE48EN
iData Research Inc.

US$ 6,495.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential for healing bone.

Orthopedic biomaterial products compete with products that are more established and less expensive. Thus, clinical evidence is often an important deciding factor for orthopedic biomaterials over conventional forms of therapy especially in regards to reimbursement. However, the promise seen in some products such as bone marrow concentrate generates growth despite a lack of clinical evidence and reimbursement.
EXECUTIVE SUMMARY

1.1 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET
1.3 ORTHOPEDIC GROWTH FACTOR MARKET
1.4 ORTHOPEDIC STEM CELL MARKET
1.5 ORTHOPEDIC CELL THERAPY MARKET
1.6 ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.7 ORTHOPEDIC CARTILAGE REPAIR MARKET
1.8 SPINAL MACHINED BONE ALLOGRAFT MARKET
1.9 LEADING COMPETITORS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
  Step 1: Project Initiation & Team Selection
  Step 2: Prepare Data Systems and Perform Secondary Research
  Step 3: Preparation for Interviews & Questionnaire Design
  Step 4: Performing Primary Research
  Step 5: Research Analysis: Establishing Baseline Estimates
  Step 6: Market Forecast and Analysis
  Step 7: Identify Strategic Opportunities
  Step 8: Final Review and Market Release
  Step 9: Customer Feedback and Market Monitoring

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

3.1 INTRODUCTION
  3.1.1 Bone Graft Substitutes
  3.1.2 Growth Factors
  3.1.3 Orthopedic Stem Cell Therapy
  3.1.4 Cell Therapies
  3.1.5 Hyaluronic Acid Viscosupplementation
  3.1.6 Cartilage Repair
  3.1.7 Spinal Machined Bone Allografts
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
  3.4.1 Market Drivers
  3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.6 HERFINDAHL INDEX
3.7 MERGERS AND ACQUISITIONS

PROCEDURE NUMBERS

4.1 PROCEDURAL DEFINITIONS
4.2 BONE GRAFT PROCEDURE NUMBERS BY TYPE
4.3 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
  4.3.1 By Material
  4.3.2 By Indication
4.4 GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS
4.5 STEM CELL BONE GRAFT PROCEDURE NUMBERS
4.6 CELL THERAPY TREATMENT NUMBERS
  4.6.1 Overview by Type
  4.6.2 Platelet-Rich Plasma Treatment Numbers by Indication
  4.6.3 Bone Marrow Concentrate Treatment Numbers by Indication
4.7 HYALURONIC ACID TREATMENT NUMBERS BY TYPE
4.8 CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE
4.9 SPINAL MACHINED BONE ALLOGRAFT PROCEDURE NUMBERS BY APPROACH

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
  5.2.1 By Indication
    5.2.1.1 Spine
    5.2.1.2 Trauma
    5.2.1.3 Large Joint
    5.2.1.4 Foot Reconstruction
    5.2.1.5 Craniomaxillofacial
    5.2.1.6 Oncology
  5.2.2 By Material
    5.2.2.1 Autograft
    5.2.2.2 Standard Allograft
    5.2.2.3 Demineralized Bone Matrix
    5.2.2.4 Synthetic
    5.2.2.5 Xenograft
5.3 PROCEDURE NUMBERS
  5.3.1 Bone Graft Substitutes Procedure Numbers by Material
  5.3.2 Units Per Procedure by Indication
5.4 MARKET OVERVIEW
  5.4.1 Bone Graft Substitute Market by Material
  5.4.2 Bone Graft Substitute Market by Indication
5.5 MARKET ANALYSIS AND FORECAST
  5.5.1 Total Orthopedic Bone Graft Substitute Market
  5.5.2 Bone Graft Substitute Market by Material
    5.5.2.1 Total Allograft Bone Graft Substitute Market
    5.5.2.2 Allograft Bone Graft Substitute Market by Indication
      5.5.2.2.1 Spine
        5.5.2.2.1.1 Cervical Spine
        5.5.2.2.1.2 Thoracolumbar Spine
      5.5.2.2.2 Trauma
        5.5.2.2.2.1 Non-union Trauma
        5.5.2.2.2.2 Fresh Fracture Trauma
      5.5.2.2.3 Large Joint Reconstruction
        5.5.2.2.3.1 Hip Large Joint Reconstruction
        5.5.2.2.3.2 Knee Large Joint Reconstruction
      5.5.2.2.4 Foot Reconstruction
      5.5.2.2.5 Craniomaxillofacial
      5.5.2.2.6 Oncology
    5.5.2.3 Total Demineralized Bone Matrix Market
    5.5.2.4 Demineralized Bone Matrix Market, with and without Carriers
    5.5.2.5 Demineralized Bone Matrix Market by Indication
      5.5.2.5.1 Spine
        5.5.2.5.1.1 Cervical Spine
        5.5.2.5.1.2 Thoracolumbar Spine
      5.5.2.5.2 Trauma
        5.5.2.5.2.1 Non-union Trauma
        5.5.2.5.2.2 Fresh Fracture Trauma
      5.5.2.5.3 Large Joint Reconstruction
        5.5.2.5.3.1 Hip Large Joint Reconstruction
        5.5.2.5.3.2 Knee Large Joint Reconstruction
      5.5.2.5.4 Foot Reconstruction
      5.5.2.5.5 Craniomaxillofacial
      5.5.2.5.6 Oncology
    5.5.2.6 Total Synthetic Bone Graft Substitute Market
    5.5.2.7 Synthetic Bone Graft Substitute Market by Indication
      5.5.2.7.1 Spine
        5.5.2.7.1.1 Cervical Spine
        5.5.2.7.1.2 Thoracolumbar Spine
      5.5.2.7.2 Trauma
        5.5.2.7.2.1 Non-union Trauma
        5.5.2.7.2.2 Fresh Fracture Trauma
      5.5.2.7.3 Large Joint Reconstruction
        5.5.2.7.3.1 Hip Large Joint Reconstruction
        5.5.2.7.3.2 Knee Large Joint Reconstruction
      5.5.2.7.4 Foot Reconstruction
      5.5.2.7.5 Craniomaxillofacial
      5.5.2.7.6 Oncology
  5.5.3 Bone Graft Substitute Market by Indication
    5.5.3.1 Spine Bone Graft Substitute Market
      5.5.3.1.1 Cervical Spine Bone Graft Substitute Market
      5.5.3.1.2 Thoracolumbar Spine Bone Graft Substitute Market
    5.5.3.2 Trauma Bone Graft Substitute Market
      5.5.3.2.1 Non-union Trauma Fracture Bone Graft Substitute Market
      5.5.3.2.2 Fresh Fracture Trauma Bone Graft Substitute Market
    5.5.3.3 Large Joint Reconstruction Bone Graft Substitute Market
      5.5.3.3.1 Hip Large Joint Reconstruction Bone Graft Substitute Market
      5.5.3.3.2 Knee Large Joint Reconstruction Bone Graft Substitute Market
    5.5.3.4 Foot Reconstruction Bone Graft Substitute Market
    5.5.3.5 Craniomaxillofacial Bone Graft Substitute Market
    5.5.3.6 Oncology Bone Graft Substitute Market
5.6 DRIVERS AND LIMITERS
  5.6.1 Market Drivers
    5.6.1.1 Allograft Bone Graft Substitute Market
    5.6.1.2 Demineralized Bone Matrix Bone Graft Substitute Market
    5.6.1.3 Synthetic Bone Graft Substitute Market
  5.6.2 Market Limiters
    5.6.2.1 Allograft Bone Graft Substitute Market
    5.6.2.2 Demineralized Bone Matrix Bone Graft Substitute Market
    5.6.2.3 Synthetic Bone Graft Substitute Market
5.7 COMPETITIVE ANALYSIS

ORTHOPEDIC GROWTH FACTOR MARKET

6.1 INTRODUCTION
  6.1.1 BMP-2 (Medtronic)
  6.1.2 BMP-7 (Olympus Biomaterials)
6.2 MARKET ANALYSIS AND FORECAST
6.3 DRIVERS AND LIMITERS
  6.3.1 Market Drivers
  6.3.2 Market Limiters
6.4 COMPETITIVE ANALYSIS

ORTHOPEDIC STEM CELL MARKET

7.1 INTRODUCTION
  7.1.1 Lineage
    7.1.1.1 Human Embryonic Stem Cells (hESC)
    7.1.1.2 Mesenchymal Stem Cells (MSC)
  7.1.2 Other Therapeutic Applications
7.2 MARKET OVERVIEW
  7.2.1 Orthopedic Stem Cell Market by Anatomy
7.3 MARKET ANALYSIS AND FORECAST
  7.3.1 Total Orthopedic Stem Cell Market
  7.3.2 Cervical Spine Stem Cell Market
  7.3.3 Lumbar Spine Stem Cell Market
7.4 DRIVERS AND LIMITERS
  7.4.1 Market Drivers
  7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS

ORTHOPEDIC CELL THERAPY MARKET

8.1 INTRODUCTION
  8.1.1 Platelet-Rich Plasma
  8.1.2 Concentrated Bone Marrow Aspirate
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
  8.3.1 Total Platelet-Rich Plasma Market
    8.3.1.1 Soft Tissue Platelet-Rich Plasma Market
    8.3.1.2 Orthopedic Platelet-Rich Plasma Market
    8.3.1.3 Cardiac Platelet-Rich Plasma Market
    8.3.1.4 Spine Platelet-Rich Plasma Market
    8.3.1.5 Plastics Platelet-Rich Plasma Market
  8.3.2 Total Bone Marrow Concentrate Market
    8.3.2.1 Spine Bone Marrow Concentrate Market
    8.3.2.2 Trauma Bone Marrow Concentrate Market
    8.3.2.3 Soft Tissue Concentrated Bone Marrow Aspirate Market
    8.3.2.4 Joint Reconstruction Bone Marrow Concentrate Market
8.4 DRIVERS AND LIMITERS
  8.4.1 Market Drivers
  8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS

ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

9.1 INTRODUCTION
  9.1.1 Benefits of Viscosupplementation
  9.1.2 Synovial Fluid
  9.1.3 Product Types
    9.1.3.1 Single-Injection Products
    9.1.3.2 Three-Injection Cycle Products
    9.1.3.3 Three/Five-Injection Cycle Products
  9.1.4 Reimbursement
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
  9.3.1 Total Hyaluronic Acid Viscosupplementation Market
  9.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
  9.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market
  9.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market
9.4 DRIVERS AND LIMITERS
  9.4.1 Market Drivers
  9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS

ORTHOPEDIC CARTILAGE REPAIR MARKET

10.1 INTRODUCTION
  10.1.1 Anatomy
  10.1.2 Methods for Cartilage Repair
    10.1.2.1 Microfracture
    10.1.2.2 Microfracture Adjunct
    10.1.2.3 Osteoarticular Autograft Transfer System
    10.1.2.4 Particulated Juvenile Allograft
    10.1.2.5 Osteochondral Allograft Transfer
    10.1.2.6 Autologous Chondrocyte Implantation
    10.1.2.7 Meniscal Allograft Transplantation
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
  10.3.1 Osteochondral Allograft Market
  10.3.2 Meniscal Allograft Market
  10.3.3 Autologous Chondrocyte Implantation Market
  10.3.4 Particulated Juvenile Allograft Implant Market
  10.3.5 Microfracture Adjunct Market
10.4 DRIVERS AND LIMITERS
  10.4.1 Market Drivers
  10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS

SPINAL MACHINED BONE ALLOGRAFT MARKET

11.1 INTRODUCTION
  11.1.1 Anterior Lumbar Interbody Fusion (ALIF)
  11.1.2 Posterior Lumbar Interbody Fusion (PLIF)
  11.1.3 Transforaminal Lumbar Interbody Fusion (TLIF)
  11.1.4 Lateral Lumbar Interbody Fusion (LLIF)
  11.1.5 Cervical Interbody Fusion (CIF)
  11.1.6 Machined Bone Material
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
  11.3.1 Total Spinal Machined Bone Allograft Market
  11.3.2 ALIF Machined Bone Allograft Market
    11.3.2.1 PLIF Machined Bone Allograft Market
    11.3.2.2 TLIF Machined Bone Allograft Market
    11.3.2.3 CIF Machined Bone Allograft Market
11.4 DRIVERS AND LIMITERS
  11.4.1 Market Drivers
  11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

LIST OF CHARTS

Chart 1 1: Orthopedic Biomaterials Market, U.S., 2011 – 2021
Chart 1 2: Orthopedic Bone Graft Substitute Market Growth by Segment, U.S., 2014, 2017 and 2021
Chart 1 3: Orthopedic Growth Factor Market, U.S., 2011, 2014, 2017 and 2021
Chart 1 4: Orthopedic Stem Cell Market by Segment, U.S., 2014 and 2021
Chart 1 5: Orthopedic Cell Therapy Market by Segment, U.S., 2011 – 2021
Chart 1 6: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown by Segment, U.S., 2011, 2014, 2017 and 2021
Chart 1 7: Orthopedic Cartilage Repair Market by Segment, U.S., 2014
Chart 1 8: Spinal Machined Bone Allograft Market by Segment, U.S., 2013 – 2015
Chart 1 9: Leading Competitors, Orthopedic Biomaterials Market U.S., 2014
Chart 3 1: Orthopedic Biomaterials Market by Segment, U.S., 2011 – 2021
Chart 3 2: Orthopedic Biomaterials Market Breakdown, U.S., 2014
Chart 3 3: Orthopedic Biomaterials Market Breakdown, U.S., 2021
Chart 3 4: Orthopedic Biomaterials Market Growth by Segment, U.S., 2011 – 2021
Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2014
Chart 3 6: Herfindahl Index, Orthopedic Biomaterials Market, U.S., 2014
Chart 4 1: Bone Graft Procedure Numbers By Type, U.S., 2011 – 2021
Chart 4 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2011 – 2021
Chart 4 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2011 – 2021
Chart 4 4: Growth Factor Bone Graft Procedure Numbers, U.S., 2011 – 2021
Chart 4 5: Stem Cell Bone Graft Procedure Numbers, U.S., 2011 – 2021
Chart 4 6: Cell Therapy Treatment Numbers by Type, U.S., 2011 – 2021
Chart 4 7: Platelet-Rich Plasma Treatment Numbers By Indication, U.S., 2011 – 2021
Chart 4 8: Bone Marrow Concentrate Treatment Numbers By Indication, U.S., 2011 – 2021
Chart 4 9: Hyaluronic Acid Treatment Numbers By Type, U.S., 2011 – 2021
Chart 4 10: Cartilage Repair Procedure Numbers By Type, U.S., 2011 – 2021
Chart 4 11: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2011 – 2021
Chart 5 1: Bone Graft Substitute Procedure Numbers By Material, U.S., 2011 – 2021
Chart 5 2: Orthopedic Bone Graft Substitute Market by Material, U.S., 2011 – 2021
Chart 5 3: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2014
Chart 5 4: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2021
Chart 5 5: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2011 – 2021
Chart 5 6: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2014
Chart 5 7: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2021
Chart 5 8: Total Orthopedic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 9: Total Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 10: Allograft Bone Graft Substitute Market by Indication, U.S., 2011 – 2021
Chart 5 11: Total Spine Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 12: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 13: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 14: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 15: Non-union Trauma Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 16: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 17: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 18: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 19: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 20: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 21: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 22: Oncology Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 23: Total Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 24: Demineralized Bone Matrix Market by Indication, U.S., 2011 – 2021
Chart 5 25: Spine Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 26: Cervical Spine Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 27: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 28: Trauma Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 29: Non-union Trauma Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 30: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 31: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 32: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 33: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 34: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 35: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 36: Oncology Demineralized Bone Matrix Market, U.S., 2011 – 2021
Chart 5 37: Total Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 38: Synthetic Bone Graft Substitute Market by Indication, U.S., 2011 – 2021
Chart 5 39: Spine Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 40: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 41: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 42: Trauma Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 43: Non-union Trauma Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 44: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 45: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 46: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 47: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 48: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 49: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 50: Oncology Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 51: Spine Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 52: Cervical Spine Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 53: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 54: Trauma Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 55: Non-union Trauma Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 56: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 57: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 58: Hip Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 59: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 60: Foot Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 61: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 62: Oncology Bone Graft Substitute Market, U.S., 2011 – 2021
Chart 5 63: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2014
Chart 6 1: Orthopedic Growth Factor Market, U.S., 2011 – 2021
Chart 6 2: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2014
Chart 7 1: Orthopedic Stem Cell Market by Anatomy, U.S., 2011 – 2021
Chart 7 2: Total Orthopedic Stem Cell Market, U.S., 2011 – 2021
Chart 7 3: Cervical Spine Stem Cell Market, U.S., 2011 – 2021
Chart 7 4: Lumbar Spine Stem Cell Market, U.S., 2011 – 2021
Chart 7 5: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2014
Chart 8 1: Orthopedic Cell Therapy Market by Segment, U.S., 2011 – 2021
Chart 8 2: Orthopedic Cell Therapy Market Breakdown, U.S., 2014
Chart 8 3: Orthopedic Cell Therapy Market Breakdown, U.S., 2021
Chart 8 4: Total Platelet-Rich Plasma Market, U.S., 2011 – 2021
Chart 8 5: Soft Tissue Platelet-Rich Plasma Market, U.S., 2011 – 2021
Chart 8 6: Orthopedic Platelet-Rich Plasma Market, U.S., 2011 – 2021
Chart 8 7: Cardiac Platelet-Rich Plasma Market, U.S., 2011 – 2021
Chart 8 8: Spine Platelet-Rich Plasma Market, U.S., 2011 – 2021
Chart 8 9: Plastics Platelet-Rich Plasma Market, U.S., 2011 – 2021
Chart 8 10: Total Bone Marrow Concentrate Market, U.S., 2011 – 2021
Chart 8 11: Spine Bone Marrow Concentrate Market, U.S., 2011 – 2021
Chart 8 12: Trauma Bone Marrow Concentrate Market, U.S., 2011 – 2021
Chart 8 13: Soft Tissue Bone Marrow Concentrate Market, U.S., 2011 – 2021
Chart 8 14: Joint Reconstruction Bone Marrow Concentrate Market, U.S., 2011 – 2021
Chart 8 15: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2014
Chart 9 1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2011 – 2021
Chart 9 2: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2014
Chart 9 3: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2021
Chart 9 4: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2011 – 2021
Chart 9 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2011 – 2021
Chart 9 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2011 – 2021
Chart 9 7: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2014
Chart 10 1: Orthopedic Cartilage Repair Market by Segment, U.S., 2011 – 2021
Chart 10 2: Orthopedic Cartilage Repair Market Breakdown, U.S., 2014
Chart 10 3: Orthopedic Cartilage Repair Market Breakdown, U.S., 2021
Chart 10 4: Osteochondral Allograft Market, U.S., 2011 – 2021
Chart 10 5: Meniscal Allograft Market, U.S., 2011 – 2021
Chart 10 6: Autologous Chondrocyte Implantation Market, U.S., 2011 – 2021
Chart 10 7: Particulated Juvenile Allograft Implant Market, U.S., 2011 – 2021
Chart 10 8: Microfracture Adjunct Market, U.S., 2011 – 2021
Chart 10 9: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2014
Chart 11 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2011 – 2021
Chart 11 2: Spinal Machined Bone Allograft Market Breakdown, U.S., 2014
Chart 11 3: Spinal Machined Bone Allograft Market Breakdown, U.S., 2021
Chart 11 4: Total Spinal Machined Bone Allograft Market, U.S., 2011 – 2021
Chart 11 5: ALIF Machined Bone Allograft Market, U.S., 2011 – 2021
Chart 11 6: PLIF Machined Bone Allograft Market, U.S., 2011 – 2021
Chart 11 7: TLIF Machined Bone Allograft Market, U.S., 2011 – 2021
Chart 11 8: CIF Machined Bone Allograft Market, U.S., 2011 – 2021
Chart 11 9: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2014

LIST OF FIGURES

Figure 3 1: Orthopedic Biomaterials Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 3 2: Orthopedic Biomaterials Market Growth by Segment, U.S., 2011 – 2021
Figure 3 3: Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2014
Figure 3 4: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2014 (Part 1 of 2)
Figure 3 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2014 (Part 2 of 2)
Figure 3 6: Herfindahl Index, Orthopedic Biomaterials Market, U.S., 2014
Figure 4 1: Bone Graft Procedure Numbers By Type, U.S., 2011 – 2021
Figure 4 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2011 – 2021
Figure 4 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2011 – 2021
Figure 4 4: Growth Factor Bone Graft Procedure Numbers, U.S., 2011 – 2021
Figure 4 5: Stem Cell Bone Graft Procedure Numbers, U.S., 2011 – 2021
Figure 4 6: Cell Therapy Treatment Numbers by Type, U.S., 2011 – 2021
Figure 4 7: Platelet-Rich Plasma Treatment Numbers By Indication, U.S., 2011 – 2021
Figure 4 8: Bone Marrow Concentrate Treatment Numbers By Indication, U.S., 2011 – 2021
Figure 4 9: Hyaluronic Acid Treatment Numbers By Type, U.S., 2011 – 2021
Figure 4 10: Cartilage Repair Procedure Numbers By Type, U.S., 2011 – 2021
Figure 4 11: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2011 – 2021
Figure 5 1: Bone Graft Substitute Procedure Numbers By Material, U.S., 2011 – 2021
Figure 5 2: Units per Procedure by Indication, Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 3: Orthopedic Bone Graft Substitute Market by Material, U.S., 2011 – 2021 (US$M)
Figure 5 4: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2011 – 2021 (US$M)
Figure 5 5: Total Orthopedic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 6: Total Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 7: Allograft Bone Graft Substitute Market by Indication, U.S., 2011 – 2021 (US$M)
Figure 5 8: Total Spine Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 9: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 10: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 11: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 12: Non-union Trauma Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 13: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 14: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 15: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 16: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 17: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 18: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 19: Oncology Allograft Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 20: Total Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 21: Demineralized Bone Matrix Market (with Carriers), U.S., 2011 – 2021
Figure 5 22: Demineralized Bone Matrix Market (without Carriers), U.S., 2011 – 2021
Figure 5 23: Demineralized Bone Matrix Market by Indication, U.S., 2011 – 2021 (US$M)
Figure 5 24: Spine Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 25: Cervical Spine Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 26: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 27: Trauma Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 28: Non-union Trauma Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 29: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 30: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 31: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 32: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 33: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 34: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 35: Oncology Demineralized Bone Matrix Market, U.S., 2011 – 2021
Figure 5 36: Total Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 37: Synthetic Bone Graft Substitute Market by Indication, U.S., 2011 – 2021 (US$M)
Figure 5 38: Spine Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 39: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 40: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 41: Trauma Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 42: Non-union Trauma Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 43: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 44: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 45: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 46: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 47: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 48: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 49: Oncology Synthetic Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 50: Spine Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 51: Cervical Spine Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 52: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 53: Trauma Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 54: Non-union Trauma Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 55: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 56: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 57: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 58: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 59: Foot Reconstruction Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 60: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 61: Oncology Bone Graft Substitute Market, U.S., 2011 – 2021
Figure 5 62: Drivers and Limiters, Orthopedic Bone Graft Substitute Market, U.S., 2014
Figure 5 63: Leading Competitors, Orthopedic Bone Graft Substitute Market by Segment, U.S., 2014
Figure 6 1: Orthopedic Growth Factor Market, U.S., 2011 – 2021
Figure 6 2: Drivers and Limiters, Orthopedic Growth Factor Market, U.S., 2014
Figure 6 3: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2014
Figure 7 1: Orthopedic Stem Cell Market by Anatomy, U.S., 2011 – 2021 (US$M)
Figure 7 2: Total Orthopedic Stem Cell Market, U.S., 2011 – 2021
Figure 7 3: Cervical Spine Stem Cell Market, U.S., 2011 – 2021
Figure 7 4: Lumbar Spine Stem Cell Market, U.S., 2011 – 2021
Figure 7 5: Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2014
Figure 7 6: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2014
Figure 8 1: Orthopedic Cell Therapy Market by Segment, U.S., 2011 – 2021 (US$M)
Figure 8 2: Total Platelet-Rich Plasma Market, U.S., 2011 – 2021
Figure 8 3: Soft Tissue Platelet-Rich Plasma Market, U.S., 2011 – 2021
Figure 8 4: Orthopedic Platelet-Rich Plasma Market, U.S., 2011 – 2021
Figure 8 5: Cardiac Platelet-Rich Plasma Market, U.S., 2011 – 2021
Figure 8 6: Spine Platelet-Rich Plasma Market, U.S., 2011 – 2021
Figure 8 7: Plastics Platelet-Rich Plasma Market, U.S., 2011 – 2021
Figure 8 8: Total Bone Marrow Concentrate Market, U.S., 2011 – 2021
Figure 8 9: Spine Bone Marrow Concentrate Market, U.S., 2011 – 2021
Figure 8 10: Trauma Bone Marrow Concentrate Market, U.S., 2011 – 2021
Figure 8 11: Soft Tissue Bone Marrow Concentrate Market, U.S., 2011 – 2021
Figure 8 12: Joint Reconstruction Bone Marrow Concentrate Market, U.S., 2011 – 2021
Figure 8 13: Drivers and Limiters, Orthopedic


More Publications